Tele: 561.316.3330
Breaking Medical Device News

Saturday, October 16, 2021
HomeOptovueOptovue First to Release High Density OCT Angiography for Ophthalmology

Optovue First to Release High Density OCT Angiography for Ophthalmology

April 25, 2017

Optovue, the global leader in the development of optical coherence tomography and OCT angiography (OCTA), is the first company to offer higher density OCTA imaging that provides a significant improvement in resolution and peripheral visualization of vasculature in the eye.

Optovue notes AngioVueHD Imaging, commercially released by Optovue today, provides OCTA scans with 73 percent more sampling points* and improves image resolution by approximately 33 percent over the existing field-of-view, enabling physicians to more closely assess the fine vasculature in the eye for changes that could indicate ocular disease.

According to Nadia Waheed, M.D., MPH, associate professor of Ophthalmology at Tufts Medical School and director of the Boston Image Reading Center, “The improved density of AngioVueHD provides the high resolution resembling that of 3×3 millimeter scans – the size we previously used to obtain the highest image quality – yet in a larger, 6×6 millimeter format. As a result, we have much greater image resolution for the 6×6 millimeter field-of-view, allowing for better assessment of pathologies characterized by large or oblique lesions.”

One of the major challenges of OCTA imaging is the limited region of the eye that can be visualized for assessing fine microvasculature. Currently, the standard field-of-view for the best image quality measures 3×3 millimeters. Optovue has significantly improved image quality in the 6×6 millimeter field-of-view with the AngioVueHD update to its AngioVue® Imaging option. The feedback from early clinical evaluators of the AngioVueHD enhancements suggests the new 6×6 millimeter OCTA scan enables the improved likelihood of detecting abnormalities and assessing fine microvasculature details that would typically extend beyond the central 3×3 millimeter region.

The company also released AngioVueHD Montage, which automatically combines two high-density images – one at the central macular region (the portion of the retina responsible for central, high-resolution color vision that is possible in good light), and the other centered at the optic disc (the entry point for the major blood vessels that supply the retina) – in a 10×6 millimeter field-of-view. The ability to automatically create the montage is useful for imaging vasculature in potential pathologies that may extend into the periphery of the imaging plane.

“Extending the AngioVueHD to include an automatic montage in an even wider 10×6 millimeter format will assist me in understanding lesions as they arise outside the macula,” continued Dr. Waheed.

“AngioVueHD will become the new gold standard in OCTA imaging and it will transform the way physicians use this technology to care for their patients,” said Jay Wei, founder and chief executive officer at Optovue. “Our AngioVue platform is already providing eye care professionals with a faster, non-invasive imaging technique that provides superior image quality of retinal and choroidal microvasculature. With the new, higher density image resolution in a larger field-of-view, we have raised the bar for OCTA imaging.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Ganymed Robotics Awarded a €2.5M Grant from the EC through the EIC Accelerator Program

Ganymed Robotics is developing a radically new approach to surgical robotics by combining computer vision, a branch of artificial intelligence, and mechatronics.

Global Healthcare Exchange Announces Acquisition of Explorer Surgical

Explorer Surgical will operate as a wholly-owned subsidiary of GHX.

Arlington Scientific Broadens Product Portfolio and Further Expands its Product Offering Through the acquisition of Non-Mammalian Blocking Buffers

Arlington Scientific, Inc. (ASI) is pleased to announce that it has acquired the non-mammalian blocking buffer product line from Clark McDermith, former owner of...

Laborie Medical Technologies Acquires Pelvalon

Laborie was represented by Piper Sandler (financial advisor) and Simpson Thacher & Bartlett LLP (legal advisor). Pelvalon was represented by J.P. Morgan Securities LLC (financial advisor) and Dorsey & Whitney LLP (legal advisor).

Herculite Products, Inc. Promotes Two Employees to New Roles

Paul Flaherty Chief Strategy Officer and Marco Angelone is being promoted to the role of Chief Financial Officer.

Prof. Joseph Kvedar Added to the Sweetch Advisory Board Member

Prof. Josdeph Kvedar is the current chair of the board at the American Telemedicine Association (ATA), formerly VP of Connected Health at Mass-Gen Brigham, co-chair of the American Medical Association (AMA) Digital Medicine Payment Advisory Group, and author of The Internet of Healthy Things and The New Mobile Age.

Sid Bala Named President of HealthChampion

Sid Bala is the former president and chief executive officer of alligatortek, a custom software applications company that was acquired by HealthChampion in 2020 where he led them for 27 years after he founded the business

Cochlear Announces FDA Approval and Clearance of first-of-its-kind Remote Care Capabilities for Nucleus and Baha Systems

The FDA approval for the cochlear implant solution and FDA clearance for the Baha solution is the first step in commercializing the product offering, anticipated spring 2022, and complement Cochlear's existing Remote Care offerings.

By using this website you agree to accept Medical Device News Magazine Privacy Policy